INVO Bioscience (IVOB) Achieves Major Milestone with Infertility Device, Expands Market Reach into Brazil
INVO Bioscience Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced that the National Health Surveillance Agency (ANVISA) in Brazil has granted approval of the INVOcell for use as a Class II device, which will allow the sale of INVOcell in the Brazilian market. The approval marks a significant milestone in INVO’s history, and opens the door for INVO to tap into one of the largest markets and fastest growing economies in the world. “Approval in Brazil is a very important step in the success of INVOcell due to the strength of support…